NUVA Stock Price, Chart, Stats & News

NuVasive, Inc.
Save
2.08B
Market cap
75.00x
Current P/E
–
Forward P/E
NUVA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 72.00% |
Operating margin | 5.39% |
Pretax margin | 4.35% |
Net margin | 3.36% |
Effective tax rate | 22.77% |
ROA | 1.82% |
ROE | 4.86% |
D/E | 1.16x |
Interest coverage ratio | 3.72x |
NUVA valuation
P/E | 75.00x |
P/S | 1.73x |
P/B | 2.62x |
P/CF | 13.48x |
P/FCF | 70.22x |
P/OCF | 13.48x |
PEG | 0.56x |
EV multiple | 8.93x |
About
NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone.
Similar securities
Based on sector and market capitalization
Report issue











